Anest. intenziv. Med. 2013;24(2):84-90

Anaesthesia for CT-navigated irreversible electroporation (NanoKnifeTM)Anaesthesiology - Original Paper

Málek Jiří1,*, Šturma Jan1, Janík Václav2, Kurzová Alice1
1 Klinika anesteziologie a resuscitace 3. LF UK a FNKV Praha
2 Radiodiagnostická klinika 3. LF UK a FNKV Praha

Objective:
Progress in other medical specialities sometimes brings a challenge for the anaesthetist to adopt anaesthetic care while scarce information is available. One such example is irreversible electroporation (IRE). The aim is to describe the anaesthetic technique for IRE based on our own experience and available studies.

Design:
Observational study.
Setting:
University hospital.

Patients and methods:
Up to 1st May 2012, 14 patients were treated by IRE, one of the patients twice. We assessed the anaesthetic charts and laboratory examinations.

Results:
The study included 9 women and 5 men aged 65 ± 11 years, BMI 22.2 ± 4.4 kg/m2. The diagnoses included cancer or metastases in the liver (10), lung (3), pancreas (1) and kidney (1). The average duration of the procedure was 135 ± 38 (median 125) minutes. The main challenges included prolonged positioning on the CT table with abducted arms, extensive movements of the examination CT table and episodes of strong stimulation requiring maximal muscle relaxation. We used relaxant general anaesthesia; boluses of 1-2 mg of alfentanil were empirically chosen for analgesia during the electric discharges. Neuromuscular blockade monitoring was essential. Laboratory examinations demonstrated significant elevation of ALT and AST to maximum 10 μkat/l and bilirubin to approximately 40 μmol/l with excess of 350 μmol/l in a single patient. Renal function remained unchanged with some cases of clinically insignificant decrease in creatinine and urea levels.

Conclusion:
The optimal anaesthetic technique was based on short-acting agents and obligatory monitoring of the neuromuscular transmission. The post-operative course was usually without problems.

Keywords: general anaesthesia; anaesthetic technique; irreversible electroporation

Received: June 27, 2012; Accepted: October 21, 2012; Published: April 1, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Málek J, Šturma J, Janík V, Kurzová A. Anaesthesia for CT-navigated irreversible electroporation (NanoKnifeTM). Anest. intenziv. Med. 2013;24(2):84-90.
Download citation

References

  1. Kolombo, I. Nová technologie miniinvazivní terapie maligních tumorů - NanoKnife® [cit. 2012-06-19]. Dostupný na www:http://www.sab-medical.com/nano-knife.php
  2. Ahmed, M. et al. Principles of and advances in percutaneous ablation. Radiology, 2011, 258, p. 351-369. Go to original source... Go to PubMed...
  3. Bertacchini, C. et al. Design of an irreversible electropora-tion system for clinical use. Technol. Cancer Res. Treat., 2007, 6, p. 313-320. Go to original source... Go to PubMed...
  4. Ball, C. et al. Irreversible electroporation: a new challenge in "out of operating theater" anesthesia. Anesth. Analg., 2010, 110, p. 1305-1309. Go to original source... Go to PubMed...
  5. Thomson, K. R. et al. Investigation of the safety of irrever-sible electroporation in humans. J. Vasc. Interv. Radiol., 2011, 22, p. 611-621. Go to original source... Go to PubMed...
  6. Pech, M. et al. Irreversible electroporation of renal cell carcinoma: a first-in-man phase I clinical study. Cardiovasc. Intervent. Radiol., 2011, 34, p. 132-138. Go to original source... Go to PubMed...




Anesteziologie a intenzivní medicína

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.